Canada Pension Plan Investment Board
LRMR icon

Canada Pension Plan Investment Board’s Larimar Therapeutics LRMR Stock Holding History

Canada Pension Plan Investment Board’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Hold
59,700
– – ﹤0.01% 1614
2026
Q1 		$269K Sell
59,700
-34,300
-36% -$137K ﹤0.01% 1466
2025
Q4 		$358K Buy
+94,000
New +$366K ﹤0.01% 1440
2019
Q2 		– Sell
-187
Closed -$6K – 1376
2019
Q1 		$6K Buy
+187
New +$9.59K ﹤0.01% 1445

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Canada Pension Plan Investment Board's LRMR Position: Q2 2026 in Review

Canada Pension Plan Investment Board held its Larimar Therapeutics (LRMR) position steady in Q2 2026 at 59,700 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

Canada Pension Plan Investment Board first reported a position in LRMR in Q1 2019 and has held it in 4 quarters since. The position peaked at $358K in Q4 2025. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Canada Pension Plan Investment Board held 59,700 shares of Larimar Therapeutics worth $182K as of Q2 2026.
  • Canada Pension Plan Investment Board left its Larimar Therapeutics share count unchanged in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1614 holding.
  • Canada Pension Plan Investment Board first reported a position in Larimar Therapeutics in Q1 2019 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Larimar Therapeutics position peaked at $358K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.